SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ranbaxy Laboratories
Ranbaxy Laboratories
BSE: 500359|NSE: RANBAXY|ISIN: INE015A01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 01, 17:00
859.90
0
VOLUME 308,222
LIVE
NSE
Apr 01, 17:00
859.80
0
VOLUME 5,415,702
News on Ranbaxy Laboratories
Select Year: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Pharma's struggle to cope standards paves way for M&A deals

10.29 am | 29 Jun 2015 |  Source: Reuters

Many of its top firms are facing sanctions at some of their factories, as the US Food and Drug Administration (FDA) tightens checks and its approvals ...

See Nifty at 9300 in 2-3 months; buy RIL, SBI on dips: Pros 

3.25 pm | 27 Jun 2015 |  Source: CNBC-TV18

Jai Bala of 1857 Advisors is bullish on the Nifty and sees it at 9300 from a two to three months timeframe. According to him, it would be great if Nif...

Sun Pharma asks some Ranbaxy employees to leave

6.13 pm | 18 Jun 2015 |  Source: PTI

Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its USD 4 bil...

Stocks in news: Sun Pharma, Cipla, Orchid Chem, M&M, Bharti

8.13 am | 18 Jun 2015 |  Source: CNBC-TV18

Sun Pharma | Maruti Suzuki | Cipla | Dhanuka Agritech | Orchid Chemicals | Torrent Pharma | Talwalkars Fitness | NTPC | Mahindra and Mahindra | YES Ba...

Here are some top trading ideas from Prakash Diwan 

10.19 am | 10 Jun 2015 |  Source: CNBC-TV18

Watch the interview of Prakash Diwan of Altamount Capital with Latha Venkatesh & Sonia Shenoy on CNBC-TV18, in which he shared his readings and outloo...

'Capital flight from EMs unlikely; India structurally good' 

2.57 pm | 06 Jun 2015 |  Source: CNBC-TV18

Jai Bala of 1857 Advisors says from a long-term perspective, the structure for India is still positive. Also, with the Chinese market becoming frothy,...

More downside if monsoon disappoints; like telecom: HSBC 

10.02 am | 05 Jun 2015 |  Source: CNBC-TV18

Sriram said he was bullish on telecom stocks as earnings were beginning to stabilise and the spread of smart phones was rising...

Prefer Glenmark Pharma: Anand Tandon 

4.32 pm | 04 Jun 2015 |  Source: CNBC-TV18

Anand Tandon, Market Expert is of the view that one may prefer Glenmark Pharma....

Buy Sun Pharmaceutical Industries: Mahantesh Sabarad 

1.30 pm | 03 Jun 2015 |  Source: CNBC-TV18

Mahantesh Sabarad, Deputy VP of Research at SBI Capital Securities recommends buying Sun Pharmaceutical Industries....

Six in Sixty: Stocks you should keep on your radar 

2.54 pm | 01 Jun 2015 |  Source: CNBC-TV18

CNBC-TV18's Reema Tendulkar lists out stocks that you should focus on – Sun Pharma, Ranbaxy, Cipla, L&T, Maruti, Eicher, Ashok Leyland, Escorts, RIL...

See downside of 5-7% in Sun Pharma: Sachin Shah 

2.03 pm | 01 Jun 2015 |  Source: CNBC-TV18

Sachin Shah of Emkay Investment Managers is of the view that one may see 5-7 percent downside in Sun Pharmaceutical Industries....

Integration costs to continue into FY16: Sun Pharma 

1.19 pm | 01 Jun 2015 |  Source: CNBC-TV18

Sun Pharma CFO Uday Baldota said given the complexity of the merger, it is difficult to give guidance for FY16, adding that the company is undertaking...

Sun will turn Ranbaxy profitable; stock fall brief: Angel 

1.04 pm | 01 Jun 2015 |  Source: CNBC-TV18

Sarabjit Kaur Nangra of Angel Broking is neutral on Cipla as of now because the price has run up ahead of fundamentals....

India Inc's M&A deal value shrinks in April: Grant Thornton

8.37 pm | 29 May 2015 |  Source: PTI

In April 2014, there were 48 transactions worth USD 6.8 billion, the report by Grant Thornton said....

Ranbaxy effect playing on Sun Pharma's margins: Pros 

7.18 pm | 29 May 2015 |  Source: CNBC-TV18

Sarabjit Kour Nangra, VP- Research, Angel Broking, believes it to be the Ranbaxy effect. However, she says 14.5 percent is very low, because after con...

Sun Pharma Q4 profit seen up 9.7%, sales may rise 16%: Poll 

5.02 pm | 28 May 2015 |  Source: CNBC-TV18

Drug major Sun Pharmaceutical Industries's fourth quarter consolidated profit is likely to increase 9.7 percent year-on-year to Rs 1,659.85 crore, acc...

Sun Pharma maintains 13-15% FY15 topline guidance: CFO 

2.54 pm | 18 Feb 2015 |  Source: CNBC-TV18

The company has grown faster than the market in India and would be focused on research and development (R&D) spends going forward, said Uday Baldota, ...

Operating performance may hurt Sun Pharma's Q3 profit: Poll

2.46 pm | 13 Feb 2015 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries will announce its third quarter earnings on Saturday. According to a CNBC-TV18 poll, net profit of the drug maker may ri...

Buy Ranbaxy Labs; target of Rs 800: Motilal Oswal

4.52 pm | 30 Jan 2015 |  Source: Moneycontrol.com

Brokerage house Motilal Oswal is bullish on Ranbaxy Laboratories and has recommended buy rating on the stock with a target price of Rs 800, in its res...

Accumulate Ranbaxy; target Rs 780: KRChoksey

4.50 pm | 30 Jan 2015 |  Source: Moneycontrol.com

KRChoksey is bullish on Ranbaxy Laboratories and has recommended accumulate rating on the stock with a target price of Rs 780 in its January 29, 2015 ...

1 2 3
Quick Links for Ranbaxy Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.